Details
Stereochemistry | ACHIRAL |
Molecular Formula | H4N |
Molecular Weight | 18.0385 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 1 |
SHOW SMILES / InChI
SMILES
[NH4+]
InChI
InChIKey=QGZKDVFQNNGYKY-UHFFFAOYSA-O
InChI=1S/H3N/h1H3/p+1
DescriptionSources: http://www.hmdb.ca/metabolites/HMDB41827
Sources: http://www.hmdb.ca/metabolites/HMDB41827
The ammonium cation is a positively charged polyatomic ion with the chemical formula NH4+. Ammonium ions are a waste product of the metabolism of animals. In fish and aquatic invertebrates, it is excreted directly into the water. In mammals, sharks, and amphibians, it is converted in the urea cycle to urea, because urea is less toxic and can be stored more efficiently. In birds, reptiles, and terrestrial snails, metabolic ammonium is converted into uric acid, which is solid and can therefore be excreted with minimal water loss. Ammonium is an important source of nitrogen for many plant species, especially those growing on hypoxic soils. However, it is also toxic to most crop species and is rarely applied as a sole nitrogen source. The ammonium ion (NH4+) in the body plays an important role in the maintenance of acid-base balance. The kidney uses ammonium (NH4+) in place of sodium (Na+) to combine with fixed anions in maintaining acid-base balance, especially as a homeostatic compensatory mechanism in metabolic acidosis. When a loss of hydrogen ions (H+) occurs and serum chloride (Cl–) decreases, sodium is made available for combination with bicarbonate (HCO3–). This creates an excess of sodium bicarbonate (NaHCO3) which leads to a rise in blood pH and a state of metabolic alkalosis. The therapeutic effects of Ammonium (as Ammonium Chloride) depend upon the ability of the kidney to utilize ammonia in the excretion of an excess of fixed anions and the conversion of ammonia to urea by the liver, thereby liberating hydrogen (H+) and chloride (Cl–) ions into the extracellular fluid.
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
A triphosphopyridine nucleotide-specific nitrite reductase from Escherichia coli. | 1961 Dec |
|
The nitrogen-fixing complex of bacteria. | 1975 Mar 31 |
|
Effects of glutamate and sulphur containing amino acids on ammonia toxicity and methionine sulphoximine convulsions in mice. | 1976 Jun 18 |
|
Possible mechanisms of anti-cholinergic drug-induced bradycardia. | 1988 |
|
Cytoprotective effect of plasmin inhibitor on necrotizing agent-induced gastric lesions in rats. | 1989 May |
|
Effects of valproate and citrulline on ammonium-induced encephalopathy. | 1994 Jan-Feb |
|
Characterization of rabbit UDP-glucuronosyltransferase UGT1A7: tertiary amine glucuronidation is catalyzed by UGT1A7 and UGT1A4. | 1997 Aug 15 |
|
Ammonia as an attractive component of host odour for the yellow fever mosquito, Aedes aegypti. | 1999 Dec |
|
Structure of cytochrome c nitrite reductase. | 1999 Jul 29 |
|
Helicobacter pylori and ammonia concentrations of whole, parotid and submandibular/sublingual saliva. | 1999 Jun |
|
Effects of L-arginine on picrotoxin-induced increase in brain ammonia concentrations and convulsions in rats. | 1999 Oct |
|
Influence of ammonia on sodium absorption in rat proximal colon. | 2000 Aug |
|
Rye bread improves bowel function and decreases the concentrations of some compounds that are putative colon cancer risk markers in middle-aged women and men. | 2000 Sep |
|
Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis. | 2001 Aug |
|
[Detection of myocardial lesion in patients with acute ammonia poisoning]. | 2003 Aug |
|
Pathogenesis of hepatic encephalopathy: update on molecular mechanisms. | 2003 Dec |
|
Functional identification of ion binding sites at the internal end of the pore in Shaker K+ channels. | 2003 May 15 |
|
Pharmacokinetic considerations in development of a bioartificial liver. | 2004 |
|
Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure. | 2005 |
|
Chronic exposure to ammonia alters the modulation of phosphorylation of microtubule-associated protein 2 by metabotropic glutamate receptors 1 and 5 in cerebellar neurons in culture. | 2005 |
|
Mechanisms of ammonia-induced astrocyte swelling. | 2005 Dec |
|
Cerebral ammonia uptake and accumulation during prolonged exercise in humans. | 2005 Feb 15 |
|
Effect of the herbal medicine Dai-kenchu-to for serum ammonia in hepatectomized patients. | 2005 Jan-Feb |
|
Anti-inflammatory effects of inhibiting the amine oxidase activity of semicarbazide-sensitive amine oxidase. | 2005 Nov |
|
Role of ammonia and nitric oxide in the decrease in plasma prolactin levels in prehepatic portal hypertensive male rats. | 2006 |
|
Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. | 2006 Apr |
|
Renal expression of the ammonia transporters, Rhbg and Rhcg, in response to chronic metabolic acidosis. | 2006 Feb |
|
Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors. | 2006 Jul |
|
[The most frequent allergens in allergic contact dermatitis]. | 2006 Jul 14 |
|
Expression of the ammonia transporter, rh C glycoprotein, in normal and neoplastic human kidney. | 2006 Oct |
|
cAMP mediates ammonia-induced programmed cell death in the microglial cell line BV-2. | 2007 Apr |
|
Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy. | 2007 Aug |
|
Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. | 2008 |
|
Encapsulation of glutamine synthetase in mouse erythrocytes: a new procedure for ammonia detoxification. | 2008 Dec |
|
Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase. | 2008 Dec |
|
Ammonia inhibits the C-type natriuretic peptide-dependent cyclic GMP synthesis and calcium accumulation in a rat brain endothelial cell line. | 2008 May |
|
The effects of CO2 and external buffering on ammonia excretion and Rhesus glycoprotein mRNA expression in rainbow trout. | 2008 Oct |
|
Collecting duct-specific Rh C glycoprotein deletion alters basal and acidosis-stimulated renal ammonia excretion. | 2009 Jun |
|
Ammonia transport in cultured gill epithelium of freshwater rainbow trout: the importance of Rhesus glycoproteins and the presence of an apical Na+/NH4+ exchange complex. | 2009 Mar |
|
Protein kinase G is involved in ammonia-induced swelling of astrocytes. | 2009 May |
|
In vivo monitoring of extracellular 13N-glutamine derived from blood-borne 13N-ammonia in rat striatum using microdialysis with radio-LC method. | 2009 Oct 30 |
|
Ammonia toxicity to the brain: effects on creatine metabolism and transport and protective roles of creatine. | 2010 |
|
Ammonia and proinflammatory cytokines modify expression of genes coding for astrocytic proteins implicated in brain edema in acute liver failure. | 2010 Mar |
|
Glutamine synthetase in muscle is required for glutamine production during fasting and extrahepatic ammonia detoxification. | 2010 Mar 26 |
|
Role of the Rhesus glycoprotein, Rh B glycoprotein, in renal ammonia excretion. | 2010 Nov |
|
Resveratrol prevents ammonia toxicity in astroglial cells. | 2012 |
|
High brain ammonia tolerance and down-regulation of Na+:K+:2Cl(-) Cotransporter 1b mRNA and protein expression in the brain of the Swamp Eel, Monopterus albus, exposed to environmental ammonia or terrestrial conditions. | 2013 |
|
Molecular characterization of branchial aquaporin 1aa and effects of seawater acclimation, emersion or ammonia exposure on its mRNA expression in the gills, gut, kidney and skin of the freshwater climbing perch, Anabas testudineus. | 2013 |
|
Lipoic acid protects C6 cells against ammonia exposure through Na⁺-K⁺-Cl⁻ co-transporter and PKC pathway. | 2013 Oct |
|
Ammonia impairs glutamatergic communication in astroglial cells: protective role of resveratrol. | 2015 Dec |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/pro/ammonium-chloride.html
Solutions for intravenous infusion should not exceed a concentration of 1% to 2% of Ammonium Chloride.
Dosage is dependent upon the condition and tolerance of the patient. It is recommended that the contents of one to two vials (100 to 200 mEq) be added to 500 or 1000 mL of isotonic (0.9%) sodium chloride injection. The rate of intravenous infusion should not exceed 5 mL per minute in adults (approximately 3 hours for infusion of 1000 mL). Dosage should be monitored by repeated serum bicarbonate determinations.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25342595
HepG2 is a human HCC line purchased from ATCC and was cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 20 % fetal bovine serum (Invitrogen, Carlsbad, CA, USA). HCC cells were treated with rapamycin (100 mkM) as an autophagy inducer and ammonium chloride (NH4Cl, 10mkM) as an autophagy inhibitor. NH4Cl inhibited rapamycin-induced autophagy in HCC cells.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
1845-7
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
||
|
LOINC |
1844-0
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
||
|
LOINC |
14599-5
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
54S68520I4
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
PRIMARY | |||
|
Ammonium cation
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
PRIMARY | |||
|
1313310
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000176250
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
PRIMARY | |||
|
14798-03-9
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
PRIMARY | |||
|
DTXSID5043974
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
PRIMARY | |||
|
223
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
PRIMARY | |||
|
28938
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
PRIMARY | |||
|
54S68520I4
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
PRIMARY | |||
|
709
Created by
admin on Fri Dec 15 16:29:57 GMT 2023 , Edited by admin on Fri Dec 15 16:29:57 GMT 2023
|
ALTERNATIVE |
ACTIVE MOIETY